找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Breast Disease; Diagnosis and Pathol Adnan Aydiner,Abdullah Igci,Atilla Soran Book 2019Latest edition Springer Nature Switzerland AG 2019 b

[復(fù)制鏈接]
樓主: Inoculare
21#
發(fā)表于 2025-3-25 03:37:39 | 只看該作者
22#
發(fā)表于 2025-3-25 08:54:52 | 只看該作者
23#
發(fā)表于 2025-3-25 15:25:53 | 只看該作者
House in order: evaluating and improvingsed under the heading “l(fā)obular neoplasia.” Variant types of LCIS and their importance as risk factors are discussed. Common forms of invasive carcinomas, such as invasive ductal carcinoma and invasive lobular carcinoma, special types, and rarer forms and their clinical consequences are also discussed.
24#
發(fā)表于 2025-3-25 18:39:03 | 只看該作者
25#
發(fā)表于 2025-3-25 23:28:51 | 只看該作者
https://doi.org/10.1007/1-4020-3710-4ussed. In addition to the abovementioned parameters, which have places in clinical approaches as important prognostic and/or predictive pathological factors, two promising parameters (tumor-infiltrating lymphocytes (TILs) and the checkpoint receptors PD-L1 and PD-L2) are also briefly mentioned.
26#
發(fā)表于 2025-3-26 02:56:02 | 只看該作者
27#
發(fā)表于 2025-3-26 05:41:17 | 只看該作者
Controlling IT facilities (IT governance)ges and disadvantages. It appears that more time is needed to illustrate the clinical validity and clinical utility of this procedure because of the inadequate number of prospective studies, especially in the field of ctDNA. With more standardized and large studies, liquid biopsy will likely assume a place in routine practice as a reliable tool.
28#
發(fā)表于 2025-3-26 10:39:04 | 只看該作者
Prognostic and Predictive Factors,ussed. In addition to the abovementioned parameters, which have places in clinical approaches as important prognostic and/or predictive pathological factors, two promising parameters (tumor-infiltrating lymphocytes (TILs) and the checkpoint receptors PD-L1 and PD-L2) are also briefly mentioned.
29#
發(fā)表于 2025-3-26 15:25:36 | 只看該作者
30#
發(fā)表于 2025-3-26 17:10:42 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 17:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
韩城市| 密山市| 郯城县| 临武县| 招远市| 鄂州市| 和顺县| 探索| 南丹县| 礼泉县| 雷波县| 十堰市| 通河县| 基隆市| 攀枝花市| 佛山市| 泗阳县| 江达县| 湛江市| 岳普湖县| 左云县| 柯坪县| 杨浦区| 南郑县| 读书| 云南省| 黑龙江省| 盐津县| 西畴县| 镇安县| 汾西县| 涟源市| 安新县| 招远市| 大田县| 涪陵区| 弋阳县| 中方县| 偃师市| 潮安县| 奉化市|